Video Experimental Relacionado
Updated: Sep 9, 2025
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
Enfermedad inflamatoria monogénica del intestino: un enigma en desarrollo
Upasana Ghosh1, Arghya Samanta2
1Department of Pediatric Gastroenterology, Post Graduate Institute of Child Health, Noida 201303, Uttar Pradesh, India.
World journal of clinical pediatrics
|August 29, 2025
Resumen
La enfermedad inflamatoria intestinal monogénica (EII) surge de mutaciones genéticas específicas, que difieren significativamente de la EII común. Comprender estas formas genéticas es crucial para un tratamiento y un pronóstico efectivos.
Área de la Ciencia:
- Gastroenterología
- La genética
- Inmunología
Sus antecedentes:
- La enfermedad inflamatoria intestinal (EII) abarca los trastornos crónicos del tracto gastrointestinal caracterizados por una inflamación recurrente.
- La EII puede derivarse de interacciones entre genes y medio ambiente o condiciones monogénicas debido a mutaciones patógenas que afectan los mecanismos protectores del intestino.
- Aproximadamente entre el 10% y el 15% de los casos de EII de aparición muy temprana pueden tener una causa monogénica subyacente.
Objetivo del estudio:
- Revisar exhaustivamente la enfermedad inflamatoria intestinal monogénica (EII).
- Discutir la epidemiología, la presentación clínica y los enfoques de diagnóstico para la EII monogénica.
- Explorar los retos terapéuticos y los avances recientes en el manejo de la EII monogénica.
Principales métodos:
- Revisión de la literatura sobre la enfermedad inflamatoria monogénica del intestino.
- Análisis de los datos epidemiológicos.
- Síntesis de la presentación clínica y las estrategias de diagnóstico.
- Revisión de las modalidades terapéuticas actuales y emergentes.
Principales resultados:
- La EII monogénica presenta fundamentos moleculares distintos, edad de aparición, comorbilidades extraintestinales y respuestas al tratamiento en comparación con la EII poligénica.
- La identificación de mutaciones genéticas específicas es clave para comprender los mecanismos de la enfermedad.
- Las estrategias terapéuticas adaptadas son esenciales para obtener resultados óptimos en los pacientes.
Conclusiones:
- La EII monogénica representa una entidad distinta que requiere un conocimiento especializado.
- El diagnóstico preciso y la comprensión de la base genética son vitales para el pronóstico y la selección del tratamiento.
- La investigación continua sobre la EII monogénica impulsará la innovación terapéutica y mejorará la atención al paciente.
Palabras clave:
Enfermedad inflamatoria del intestinoEnfermedad inflamatoria monogénica del intestinoInmunodeficiencia primariaEnfermedad inflamatoria intestinal de inicio muy precozSecuenciación completa del exomaMás Videos Relacionados
05:08A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
4.0K
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
22.3K
Videos de Conceptos Relacionados
01:30Inflammatory Bowel Disease II: Crohn's Disease
375
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
375
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
01:17Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
01:17Irritable Bowel Syndrome I: Introduction
369
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
369
01:29Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185